MTOR and acute myeloid leukemia: As the mTOR activation seemed to be associated to DEK-CAN we investigated mTOR activation in FKH1 cells and showed that phosphorylated AKT and pS6 levels were higher in FKH1 cells than in other AML cells such as U937 or Kasumi1 cells (Fig. 5B).